Literature DB >> 31410640

Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System® (PROMIS®) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting.

Nan E Rothrock1, Karon F Cook2, Mary O'Connor2, David Cella2, Ashley Wilder Smith3, Susan E Yount2.   

Abstract

PURPOSE: Patient-Reported Outcomes Measurement Information System® (PROMIS®) physical function, cognitive function, and sleep disturbance measures are increasingly used in cancer care. However, there is limited guidance for interpreting the clinical meaning of scores. This study aimed to apply bookmarking, a standard setting methodology, to identify PROMIS score thresholds in the context of cancer care.
METHODS: Using item parameters, we constructed vignettes of five items covering the range of possible scores. Focus groups were held with cancer care providers and people with cancer. Terminology for categorizing levels of severity was explored. Participants rank ordered vignettes by severity and then placed bookmarks between vignettes representing different levels of severity. Group discussion was held until consensus on bookmark placement was reached.
RESULTS: Clinicians selected "within normal limits," "mild," "moderate," and "severe" to describe levels of severity. Both patients and clinicians were able to apply these labels, but there was not unanimous support for any set of descriptors. Clinicians and patients agreed on all severity thresholds for sleep disturbance. For cognitive and physical function, clinicians and patients agreed on the threshold between "within normal limits" and "mild." However, patients required greater dysfunction than clinicians before applying "moderate" and "severe" labels.
CONCLUSIONS: Bookmarking can be applied to develop provisional score interpretation for PROMIS measures. Patients and clinicians were frequently consistent in their bookmark placement. When there was variance, patients required more dysfunction before assigning more severity. Additional research with other cancer samples is needed to evaluate the replicability and generalizability of our findings.

Entities:  

Keywords:  Cognitive function; PROMIS; Patient-reported outcomes; Physical function; Reference values; Sleep

Mesh:

Year:  2019        PMID: 31410640      PMCID: PMC6868299          DOI: 10.1007/s11136-019-02261-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

1.  Asking the community about cutpoints used to describe mild, moderate, and severe pain.

Authors:  Guadalupe R Palos; Tito R Mendoza; Gary M Mobley; Scott B Cantor; Charles S Cleeland
Journal:  J Pain       Date:  2006-01       Impact factor: 5.820

2.  Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  M Rose; J B Bjorner; J Becker; J F Fries; J E Ware
Journal:  J Clin Epidemiol       Date:  2008-01       Impact factor: 6.437

3.  Interpretation of patient-reported outcomes.

Authors:  Joseph C Cappelleri; Andrew G Bushmakin
Journal:  Stat Methods Med Res       Date:  2013-02-19       Impact factor: 3.021

4.  Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care.

Authors:  Lynne I Wagner; Julian Schink; Michael Bass; Shalini Patel; Maria Varela Diaz; Nan Rothrock; Timothy Pearman; Richard Gershon; Frank J Penedo; Steven Rosen; David Cella
Journal:  Cancer       Date:  2014-11-06       Impact factor: 6.860

5.  Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.

Authors:  David Cella; Seung Choi; Sofia Garcia; Karon F Cook; Sarah Rosenbloom; Jin-Shei Lai; Donna Surges Tatum; Richard Gershon
Journal:  Qual Life Res       Date:  2014-06-18       Impact factor: 4.147

6.  Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?

Authors:  Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Pain Symptom Manage       Date:  2007-12-26       Impact factor: 3.612

7.  Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases.

Authors:  Vivek Nagaraja; Constance Mara; Puja P Khanna; Rajaie Namas; Amber Young; David A Fox; Timothy Laing; William J McCune; Carol Dodge; Debra Rizzo; Maha Almackenzie; Dinesh Khanna
Journal:  Qual Life Res       Date:  2017-10-05       Impact factor: 4.147

8.  The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency.

Authors:  Matthias Rose; Jakob B Bjorner; Barbara Gandek; Bonnie Bruce; James F Fries; John E Ware
Journal:  J Clin Epidemiol       Date:  2014-05       Impact factor: 6.437

9.  Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer.

Authors:  Martin G Seneviratne; Selen Bozkurt; Manali I Patel; Tina Seto; James D Brooks; Douglas W Blayney; Allison W Kurian; Tina Hernandez-Boussard
Journal:  Cancer       Date:  2018-12-04       Impact factor: 6.921

10.  What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability.

Authors:  Claire F Snyder; Katherine C Smith; Elissa T Bantug; Elliott E Tolbert; Amanda L Blackford; Michael D Brundage
Journal:  Cancer       Date:  2017-01-13       Impact factor: 6.860

View more
  10 in total

1.  Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.

Authors:  Rachel Cusatis; Kathryn E Flynn; Sumithira Vasu; Joseph Pidala; Lori Muffly; Joseph Uberti; Roni Tamari; Deborah Mattila; Alisha Mussetter; Ruta Bruzauskas; Min Chen; Erin Leckrone; Judith Myers; Lih-Wen Mau; J Douglas Rizzo; Wael Saber; Mary Horowitz; Stephanie J Lee; Linda J Burns; Bronwen Shaw
Journal:  Transplant Cell Ther       Date:  2021-10-29

2.  Cognitive impairment is associated with greater preoperative symptoms, worse health-related quality of life, and reduced likelihood of recovery after cervical and lumbar spine surgery.

Authors:  Rachel S Bronheim; Emma Cotter; Richard L Skolasky
Journal:  N Am Spine Soc J       Date:  2022-05-22

3.  COVID-19-Related Anxiety Symptoms among Quarantined Adolescents and Its Impact on Sleep Pattern Changes and Somatic Symptoms.

Authors:  Yulia Gendler; Ayala Blau
Journal:  Children (Basel)       Date:  2022-05-17

4.  Interpreting Life Impact Burn Recovery Evaluation Profile Scores for Use by Clinicians, Burn Survivors, and Researchers.

Authors:  Mary D Slavin; Colleen M Ryan; Jeffrey C Schneider; Amy Acton; Flor Amaya; Cayla Saret; Emily Ohrtman; Audrey Wolfe; Pengsheng Ni; Lewis E Kazis
Journal:  J Burn Care Res       Date:  2021-02-03       Impact factor: 1.845

5.  Can Patient-Reported Outcomes Measurement Information System® (PROMIS) measures accurately enhance understanding of acceptable symptoms and functioning in primary care?

Authors:  Ryan P Jacobson; Daniel Kang; Jeff Houck
Journal:  J Patient Rep Outcomes       Date:  2020-05-20

6.  Evaluation of PROMIS Cognitive Function Scores and Correlates in a Clinical Sample of Older Adults.

Authors:  Maria O Edelen; Jordan M Harrison; Anthony Rodriguez; Rebecca Weir; Jin-Shei Lai; Michelle M Langer; Janel Hanmer
Journal:  Gerontol Geriatr Med       Date:  2022-08-13

7.  Heterogeneity of symptoms and functions among women receiving chemotherapy for breast cancer in China: A multicentre, cross-sectional study.

Authors:  Tingting Cai; Tingting Zhou; Changrong Yuan; Chunfang Yu; Feixia Ni; Zhiren Sheng
Journal:  Front Public Health       Date:  2022-08-03

8.  A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention.

Authors:  Daniel L Hall; Beverly J Levine; Elizabeth Jeter; Allison Chandler; Janet A Tooze; Jenna Duffecy; David Victorson; William Gradishar; Joseph Leach; Thomas Saphner; Mary Lou Smith; Frank Penedo; David C Mohr; David Cella; Lynne I Wagner
Journal:  J Behav Med       Date:  2022-08-05

9.  Clinical Use of PROMIS, Neuro-QoL, TBI-QoL, and Other Patient-Reported Outcome Measures for Individual Adult Clients with Cognitive and Language Disorders.

Authors:  Matthew L Cohen; Alyssa M Lanzi; Aaron J Boulton
Journal:  Semin Speech Lang       Date:  2021-07-14       Impact factor: 1.734

10.  Screening for cognitive symptoms among cancer patients during chemotherapy: Sensitivity and specificity of a single item self-report cognitive change score.

Authors:  Joanna E Fardell; Victoria Bray; Melanie L Bell; Brooke Rabe; Haryana Dhillon; Janette L Vardy
Journal:  Psychooncology       Date:  2022-03-30       Impact factor: 3.955

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.